At Estel, we just don't sell. We care.

Shop

SUMAGLUTIDE IV (OZEMPIC) 0.5MG

6,300.00

Add to wishlist Add to compareAsk about product
SKU: A-1653 Category:

Description

Ozempic (semaglutide) is an injectable medication used to improve blood sugar control in adults with type 2 diabetes. It is also indicated to reduce the risk of major cardiovascular events, such as heart attack, stroke, or death, in adults with type 2 diabetes and known heart disease. Additionally, Ozempic helps reduce the risk of kidney disease progression, kidney failure, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease. ([ozempic.com](https://www.ozempic.com/why-ozempic/what-is-ozempic.html?utm_source=openai))

**Drug Class or Type:**
– GLP-1 receptor agonist

**General Mechanism of Action:**
– Stimulates insulin secretion in response to meals.
– Suppresses glucagon release, reducing glucose production by the liver.
– Slows gastric emptying, promoting satiety. ([webmd.com](https://www.webmd.com/drugs/2/drug-174490/semaglutide-subcutaneous/details?utm_source=openai))

**Common Forms:**
– Pre-filled pens for subcutaneous injection

**Dosage Instructions:**
– **Initiation Phase:**
– Start with 0.25 mg once weekly for 4 weeks.
– **Maintenance Phase:**
– Increase to 0.5 mg once weekly.
– If additional glycemic control is needed after at least 4 weeks, the dose may be increased to 1 mg once weekly.
– The maximum recommended dose is 2 mg once weekly. ([drugs.com](https://www.drugs.com/ozempic.html?utm_source=openai))

**Side Effects, Contraindications, or Interactions:**
– **Common Side Effects:**
– Nausea, vomiting, diarrhea, abdominal pain, and constipation.
– **Serious Risks:**
– Risk of thyroid C-cell tumors, including medullary thyroid carcinoma (MTC).
– Contraindicated in patients with a personal or family history of MTC or multiple endocrine neoplasia syndrome type 2 (MEN 2). ([novomedlink.com](https://www.novomedlink.com/diabetes/products/treatments/ozempic.html?utm_source=openai))
– **Other Considerations:**
– Not recommended for use in individuals with type 1 diabetes.
– Use with caution in patients with a history of pancreatitis.
– Monitor renal function during treatment.
– May interact with other medications; consult a healthcare provider for potential interactions.

Ozempic is intended to be used as part of a comprehensive treatment plan that includes diet and exercise. It is important to follow the prescribed dosing schedule and consult a healthcare provider for personalized medical advice.

Reviews

There are no reviews yet.

Be the first to review “SUMAGLUTIDE IV (OZEMPIC) 0.5MG”

Your email address will not be published. Required fields are marked *